David Bonekamp1,2, Katerina Deike1, Benedikt Wiestler3,4, Wolfgang Wick3,4, Martin Bendszus1, Alexander Radbruch1,4, Sabine Heiland2. 1. Department of Neuroradiology, University Hospital Heidelberg, Germany. 2. Division of Experimental Radiology, Department of Neuroradiology, University Hospital Heidelberg, Germany. 3. Department of Neurooncology, University Hospital Heidelberg, Germany. 4. German Cancer Research Center (DKFZ), Heidelberg, Germany.
Abstract
BACKGROUND: To compare intraindividual dynamic susceptibility contrast (DSC) and dynamic contrast enhanced (DCE) MR perfusion parameters and determine the association of DCE parameters with overall survival (OS) with the established predictive DSC parameter cerebral blood volume (CBV) in patients with newly diagnosed glioblastoma. METHODS: Perfusion data were analyzed retrospectively, and included scans performed preoperatively at 3.0 Tesla in 37 patients (25 males, 12 females, 39-83 years, median 65) later diagnosed with glioblastoma. All patients received standard treatment consisting of surgery and radiochemotherapy. Images were spatially coregistered and maximum region of interest-based DCE and DSC parameter measurements compared and thresholds identified using multivariate linear regression, Pearson's correlation coefficients and using receiver operating characteristic analysis. Survival analysis was performed using Kaplan-Meier curves. RESULTS: While both, elevated volume transfer constant (K(trans) ) (>0.29 min(-1) ; P = 0.041) and CBV (>23.7 mL/100 mL; P < 0.001) were significantly associated with OS, elevated CBV was associated with worse OS compared with elevated K(trans) . K(trans) was significantly correlated with the leakage correction factor K2 but not with CBV. CONCLUSION: The combined use of DSC and DCE MR perfusion may provide additional information of prognostic value for glioblastoma patient survival prediction. As K(trans) was not tightly coupled to CBV, both parameters may reflect different stages in the pathogenetic sequence of glioblastoma growth.
BACKGROUND: To compare intraindividual dynamic susceptibility contrast (DSC) and dynamic contrast enhanced (DCE) MR perfusion parameters and determine the association of DCE parameters with overall survival (OS) with the established predictive DSC parameter cerebral blood volume (CBV) in patients with newly diagnosed glioblastoma. METHODS: Perfusion data were analyzed retrospectively, and included scans performed preoperatively at 3.0 Tesla in 37 patients (25 males, 12 females, 39-83 years, median 65) later diagnosed with glioblastoma. All patients received standard treatment consisting of surgery and radiochemotherapy. Images were spatially coregistered and maximum region of interest-based DCE and DSC parameter measurements compared and thresholds identified using multivariate linear regression, Pearson's correlation coefficients and using receiver operating characteristic analysis. Survival analysis was performed using Kaplan-Meier curves. RESULTS: While both, elevated volume transfer constant (K(trans) ) (>0.29 min(-1) ; P = 0.041) and CBV (>23.7 mL/100 mL; P < 0.001) were significantly associated with OS, elevated CBV was associated with worse OS compared with elevated K(trans) . K(trans) was significantly correlated with the leakage correction factor K2 but not with CBV. CONCLUSION: The combined use of DSC and DCE MR perfusion may provide additional information of prognostic value for glioblastomapatient survival prediction. As K(trans) was not tightly coupled to CBV, both parameters may reflect different stages in the pathogenetic sequence of glioblastoma growth.
Authors: Daniel Paech; Constantin Dreher; Sebastian Regnery; Jan-Eric Meissner; Steffen Goerke; Johannes Windschuh; Johanna Oberhollenzer; Miriam Schultheiss; Katerina Deike-Hofmann; Sebastian Bickelhaupt; Alexander Radbruch; Moritz Zaiss; Andreas Unterberg; Wolfgang Wick; Martin Bendszus; Peter Bachert; Mark E Ladd; Heinz-Peter Schlemmer Journal: Eur Radiol Date: 2019-02-26 Impact factor: 5.315
Authors: Luke Macyszyn; Hamed Akbari; Jared M Pisapia; Xiao Da; Mark Attiah; Vadim Pigrish; Yingtao Bi; Sharmistha Pal; Ramana V Davuluri; Laura Roccograndi; Nadia Dahmane; Maria Martinez-Lage; George Biros; Ronald L Wolf; Michel Bilello; Donald M O'Rourke; Christos Davatzikos Journal: Neuro Oncol Date: 2015-07-16 Impact factor: 12.300
Authors: Sina Burth; Philipp Kickingereder; Oliver Eidel; Diana Tichy; David Bonekamp; Lukas Weberling; Antje Wick; Sarah Löw; Anne Hertenstein; Martha Nowosielski; Heinz-Peter Schlemmer; Wolfgang Wick; Martin Bendszus; Alexander Radbruch Journal: Neuro Oncol Date: 2016-06-13 Impact factor: 12.300
Authors: Yi Guo; R Marc Lebel; Yinghua Zhu; Sajan Goud Lingala; Mark S Shiroishi; Meng Law; Krishna Nayak Journal: Med Phys Date: 2016-05 Impact factor: 4.071
Authors: Natalia S Rost; Pedro Cougo; Svetlana Lorenzano; Hua Li; Lisa Cloonan; Mark Jrj Bouts; Arne Lauer; Mark R Etherton; Hasan H Karadeli; Patricia L Musolino; William A Copen; Ken Arai; Eng H Lo; Steve K Feske; Karen L Furie; Ona Wu Journal: J Cereb Blood Flow Metab Date: 2017-05-08 Impact factor: 6.200
Authors: Spyridon Bakas; Hamed Akbari; Aristeidis Sotiras; Michel Bilello; Martin Rozycki; Justin S Kirby; John B Freymann; Keyvan Farahani; Christos Davatzikos Journal: Sci Data Date: 2017-09-05 Impact factor: 6.444
Authors: Y S Choi; D W Kim; S-K Lee; J H Chang; S-G Kang; E H Kim; S H Kim; T H Rim; S S Ahn Journal: AJNR Am J Neuroradiol Date: 2015-09-03 Impact factor: 3.825